Determining the presence of a protein in non-tumor cells within the cancer microenvironment could be one of the keys to ...

Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a ...

A new review reveals how focal adhesion kinase (FAK) acts as a central regulator of tumor progression and immune suppression ...

Researchers are launching a new project to crack the mystery of aggressive breast cancer, where predicting disease ...

Tumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can be ...

Preclinical data demonstrate enhanced efficacy of PLT012 in pMMR colorectal cancer models - Findings position CD36 as a promising metabolic checkpoint target in an underserved patient population DOVER ...

Breast cancer is the most common form of cancer in women. According to the World Health Organization, in 2022, around 2.3 ...

Pancreatic cancer research tackles treatment resistance with targeted drug delivery, immune-boosting combinations, and ...